Cc1nn(-c2ccccc2)c2c1C(c1cc3ccccc3nc1Cl)NC(=S)N2
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?